Home > Financial Ratios > HALEOS LABS

HALEOS LABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HALEOS LABS
Please provide your vote to see the results

HALEOS LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 42.549.88-12.0713.2515.71

What is the latest Core EBITDA Growth ratio of HALEOS LABS ?

The latest Core EBITDA Growth ratio of HALEOS LABS is 42.54 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202542.54
Mar20249.88
Mar2023-12.07
Mar202213.25
Mar202115.71

How is Core EBITDA Growth of HALEOS LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 42.54
330.57
Mar2024 9.88
Positive
Mar2023 -12.07
Negative
Mar2022 13.25
-15.66
Mar2021 15.71 -

Other Financial Ratios of HALEOS LABS


Compare Core EBITDA Growth ratio of peers of HALEOS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HALEOS LABS ₹444.0 Cr -2.6% -4% 20.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


HALEOS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HALEOS LABS

-2.6%

-4%

20.8%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses